期刊文献+

鞘氨醇对人结肠癌细胞的抑制作用 被引量:3

Inhibitory effect of sphingosine on human colon HT-29 cells
下载PDF
导出
摘要 目的 研究鞘氨醇对人结肠癌细胞的影响。方法 采用四甲基偶氮唑盐法 (MTT)、细胞核分裂指数和3 H -TdR掺入试验方法 ,所设剂量鞘氨醇分别为 0 ,0 82 ,1 6 3,3 12 5 ,6 2 5 ,12 5 μmol/L ,以二甲基亚砜 (DMSO)为溶剂对照。结果 鞘氨醇对HT - 2 9细胞的生长有明显抑制作用。在MTT试验中 ,不同浓度鞘氨醇对HT - 2 9细胞的7d抑制率分别为 18% ,4 5 % ,72 % ,87%和 89% ;在核分裂指数试验中 ,随着鞘氨醇剂量的增高 ,其核分裂指数明显降低 ;在3 H -TdR掺入试验中 ,可见随着鞘氨醇剂量的增高 ,3 H -TdR掺入到HT - 2 9细胞中明显的减少 ,与阴性对照组相比有显著性差异。结论 鞘氨醇对HT - 2 9细胞的生长增殖有明显抑制作用 ,这可能是鞘磷脂抑制结肠癌的机制之一。 Objective To study the influence of sphingosine on the growth of human colon HT-29 cells in vitro .Methods Using cell culture tests(MTT test,index of cellular mitosis,and \{\}\+3H-TdR incorporation test),to examine the growth of HT-29 cells at five concentrations(0,0.82,1.63,3.125,6.25,12.5 μmol/L)with a negative control (DMSO v/v).Results Sphingosine can inhibited the growth of HT-29 cells.After treatment with various sophingosine concentrations mentioned above for 7 days,the inhibition rates were 18%,45%,72%,87% and 89% respectively.With the increase of sphingosine concentrations,\{\}\+3H-TdR incorporation was decreased in HT-29 cells and the quantity of \{\}\+3H-TdR incorporation was significantly decreased as compared with the negative control ( P <0.05).Conclusion Sphingosine can significantly inhibit the growth of HT-29 cells,which was probably one of the preventive mechanisms of sphingomyelin for colon cancer.
出处 《中国公共卫生》 CAS CSCD 北大核心 2004年第7期775-776,共2页 Chinese Journal of Public Health
基金 国家自然科学基金资助项目 (30 1 70 80 6)
关键词 鞘氨醇 人结肠癌HT-29细胞 sphingosine human conlon carcinoma (HT-29) cell
  • 相关文献

参考文献4

  • 1[1]Schmelz EM, Dillehay DL, Webb SK, et al. Sphingomyelin consumption suppresses aberrant colonic crypt foci and increases the proportion of adenomas versus adenocarcinomas in CF1 mice treated with 1, 2 - dimethylhydrazine: implications for dietary sphingolipids and coloncarcinogenesis[J]. Cancer Res, 1996, 56: 4936-4941.
  • 2张涛,李百祥,富英群.鞘磷脂及神经酰胺对人结肠癌细胞(HT-29)的影响[J].卫生毒理学杂志,2003,17(2):81-83. 被引量:4
  • 3[3]Davis MA, Flaws JA, Young M, et al. Effect of ceramide on intracellular glutathione determines apoptotic or necrotic cell death of JB6 tumor cells [J]. Toxico Sci, 2000, 53:48 - 65.
  • 4[4]Sweeney EA, Sakakura C, Shirahama T, et al. Sphingosine and its methylated derivative N, N - dimethlysphingosine (DMS) induce apoptosis in a variety of human cancer cell lines[J]. Int J Cancer,1996, 66: 358 - 366.

二级参考文献8

  • 1Harder T, Simons K. Caveolae DIGs and the dynamics of sphingolipid cholesterol microdomains. Curr Opin Cell Biol, 1997,9 :534-542.
  • 2Hannun YA, Obeid LM. Ceramide: an intracellular signal for apoptosis. Trends Biochem Sci, 1995,20 : 73-77.
  • 3Hubert V, Schmelz EM, Mariana N, et al. Sphingolipids in food and the emerging importance of sphingolipids to nutrition. J Nutr, 1999,129 : 1239-1250.
  • 4Dillehay DL, Webb SJ, Schmelz EM, et al. Dietary sphingomyelin inhibits 1,2-dimethylhydrazine-induced colon cancer in CF1 mice. J Nutr, 1994,124:615-620.
  • 5Schmelz EM,Dillehay DL, Webb SK, et al. Sphingomyelin consumption suppresses aberrant colonic crypt foci and increases the proportion of adenomas versus adenocarcinomas in CF1 mice treated with 1,2-dimethylhydrazine: implications for dietary sphingolipids and colon carcinogenesis. Cancer Res, 1996,56 : 4936-3941.
  • 6Cifone MG, De Maria R,Roncaioli P,et al. Apoptotic signaling through CD95 (Fas/Apo^-1) activates an acidic sphingomyelinase. J Exp Med, 1994,180,1547-1552.
  • 7Davis MA, Flaws JA, Young M, et al. Effect of ceramide on intracellular glutathione determines apoptotic or necrotic cell death of JB6 tumor cells. Toxicol Sci, 2000,53:48-55.
  • 8Sweeney EA, Sakakura C, Shirahama T, et al. Sphingosine and its methylated derivative N, N-dimethlysphingosine (DMS) induce apoptosis in a variety of human cancer cell lines. Int J Cancer, 1996,66 : 358-366.

共引文献3

同被引文献46

  • 1张萍,李百祥.碱性鞘磷脂酶与结肠癌发生发展之间的关系[J].癌变.畸变.突变,2008,20(5):409-411. 被引量:1
  • 2谷运璀,钱莉群,李步详,宦月琴.芳樟醇氧化物的合成[J].香料香精化妆品,2013(S1):28-31. 被引量:11
  • 3李百祥,张涛.神经酰胺诱导人结肠癌细胞凋亡的作用[J].中国公共卫生,2004,20(5):526-527. 被引量:5
  • 4Lawrence S, Antoine DL, Olivier R, et al. Ursodeoxycholic acid therapy and the risk of colorectal adenoma in patients with primary biliary cirrhosis[ J ]. Hepatology, 2003, 38 ( 1 ) : 203 - 209.
  • 5Pardi DS, Loftus EV, Kremers WK, et al. Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis [ J ]. Gastroenterology, 2003, 124 : 889 - 893.
  • 6Liu F, Cheng Y, Wu J, et al. Ursodeoxycholic acid differentially affects three types of sphingomyelinase in human colon cancer Caeo 2 cells[ J ]. Cancer Lett, 2006, 235 (1) : 141 - 146.
  • 7Cheng Y, Nilsson A, Tomquist E, et al. Purification, characterization and expression of rat intestinal alkaline sphingomyelinase [ J ]. Lip Res, 2002, 43 : 316 - 324.
  • 8Laura A, Woollett, Donna DB, et al. Etiect ol ursodeoxycholic acid on cholesterol absorption and metabolism in humans[J ]. Lip Res, 2003, 44: 935 - 942.
  • 9Eckhardt ER, Wang DQ, Donovan JM, et al. Dietary sphingomyelin suppresses intestinal cholesterol absorption by decreasing thermodynamic activity of cholesterol monomers[J ]. Gastroenterology, 2002, 122 : 948 - 956.
  • 10Hannun YA, Obeid LM. Principles of bioactive lipid signalling: lessons from sphingolipids[J] . Nat Rev Mol Cell Biol, 2008,9(2) : 139 - 150.

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部